Achieving Healthy CRO Growth Through Agility

As the number of clinical trials in the Asia-Pacific region experiences steady growth, George Clinical, a contract research organization headquartered in Sydney, Australia, strategically positioned itself for expansion, extending its reach into the well-established clinical trial markets of North America and Europe.

One key factor contributing to George Clinical's prominence—specializing in a diverse collection of therapeutic areas, including oncology, kidney and metabolic disorders, cardiovascular health, neurology, respiratory conditions, endocrinology, and medical devices—is its affiliation with the George Institute for Global Health, a renowned leader in chronic disease research and other related fields.

Around 2013, the George Institute for Global Health embarked on significant research projects that required external support, including endpoint adjudication involving a substantial number of research subjects. The institute sought assistance from Merative to help build databases for these projects and train staff on how to use the Zelta™ clinical trials platform by Merative, a clinical data management system that enables users to organize and analyze report data from anywhere in the world.

Over the last decade, George Clinical's Database Development team has witnessed substantial growth by continuing to leverage the platform for constructing clinical trial databases of varying complexity, incorporating a wide range of modules.

Notably, George Clinical recently utilized the Zelta platform to support several groundbreaking studies focused on diabetic kidney disease. These studies encompassed a significant number of patients and extensive datasets, with the endpoint adjudication feature of the solution proving exceptionally valuable in this context.

Delve into the details of how George Clinical was able to achieve this robust CRO growth by harnessing the power of agility by accessing the case study below.